WALL STREET PAYDAY: 4 banks made a killing from Monday's $20 billion in biotech deals
Scott Olson/Getty Images
- Biotech mergers and acquisitions are off to a hot start in 2018.
- On Monday, French drugmaker Sanofi spent $11.6 billion to buy US hemophilia firm Bioverativ, and Celgene spent $9 billion on cancer specialist Juno Therapeutics.
- Investment banks stand to make as much as $185 million in fees for advising on the deals.
Two major biotech acquisitions dropped on Monday: French drugmaker Sanofi spent $11.6 billion to buy US hemophilia firm Bioverativ, and Celgene spent $9 billion on cancer specialist Juno Therapeutics.
The more than $20 billion in pharma mergers and acquisitions means a windfall of as much as $185 million in fees for four investment banks, with JPMorgan raking in the most from the deals.
JPMorgan will split $45 million to $55 million in fees with Guggenheim Partners for advising Bioverativ, while Lazard will take in $30 million to $40 million for advising Sanofi, according to Jeffrey Nassof, the director of the consulting firm Freeman & Co.
JPMorgan also advised on the Celgene-Juno tieup, earning $25 million to $35 million in fees for advising Celgene. Morgan Stanley stands to make $45 million to $55 million for advising Juno.
M&A activity is off to a blistering start for the sector in 2018 - Celgene earlier this month also spent as much as $7 billion to buy Impact Biomedicines - and Monday's deals could be a "sign that large-cap Pharma's getting more aggressive again with dealmaking," according to Nassof.
There were only nine US pharma acquisitions of $5 billion or more announced in 2017, compared with 14 in 2016 and 23 in 2015, Nassof said.
- Tesla tells some laid-off employees their separation agreements are canceled and new ones are on the way
- Taylor Swift's 'The Tortured Poets Department' is the messiest, horniest, and funniest album she's ever made
- One of the world's only 5-star airlines seems to be considering asking business-class passengers to bring their own cutlery
- Stock markets stage strong rebound after 4 days of slump; Sensex rallies 599 pts
- Sustainable Transportation Alternatives
- 10 Foods you should avoid eating when in stress
- 8 Lesser-known places to visit near Nainital
- World Liver Day 2024: 10 Foods that are necessary for a healthy liver